Companion Diagnostics Market Size, Share, By Offerings (Products and Services), Technology (Polymerase Chain Reaction (PCR), Next-generation Sequencing (NGS), Immunohistochemistry (IHC), Fluorescence In Situ Hybridization (FISH), and, Others), Therapeutic Area (Oncology, Immunology, Neurology, Autoimmune, Cardiovascular, Infectious Disease, and Others), End-User (Pharmaceutical & Biotechnological Companies, Contract Research Laboratories, Diagnostics Laboratories, and Others), and Region - Trends, Analysis, and Forecast till 2035

Rising Ineffectiveness of Companion Diagnostics is Expected to Boost Market Growth

• The importance of companion diagnostics in healthcare providers with treatment decision for patient is rapidly growing. Companion diagnostics identify specific targeted therapy by detecting the presence of biomarker, allow for personalized medicine and minimizing unnecessary side effects and optimizing treatment outcomes. As the rising demand for the high-priced therapies and safer mediation, resulting to drive the companion diagnostics market growth in few years.